Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms&unknown;) and oil-in-water vaccines

By Coulter A.   Wong T.-Y.   Drane D.   Bates J.   Macfarlan R.   Cox J.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1243-1253

Elsevier

Access to resources Recommend Favorite

The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell lines

By Wilson A.D.   Lovgren-Bengtsson K.   Villacres-Ericsson M.   Morein B.   Morgan A.J.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1282-1290

Elsevier

Access to resources Recommend Favorite

Induction of local innate immune responses and modulation of antigen uptake as mechanisms underlying the mucosal adjuvant properties of immune stimulating complexes (ISCOMS)

By Furrie E.   Smith R.E.   Turner M.W.   Strobel S.   Mowat A.M.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2254-2262

Elsevier

Access to resources Recommend Favorite

Human immune responses to influenza virus vaccines administered by systemic or mucosal routes

By Moldoveanu Z.   Clements M.L.   Prince S.J.   Murphy B.R.   Mestecky J.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 1006-1012

Elsevier

Access to resources Recommend Favorite

Priming in vivo and quantification in vitro of class I MHC-restricted cytotoxic T cells to human papilloma virus type 11 early proteins (E6 and E7) using immunostimulating complexes (ISCOMs)

By Tarpey I.   Stacey S.N.   McIndoe A.   Davies D.H.  

Vaccine, Vol. 14, Iss. 3, 1996-02 ,pp. : 230-236

Elsevier

Access to resources Recommend Favorite